1. Home
  2. FIGX vs GNFT Comparison

FIGX vs GNFT Comparison

Compare FIGX & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FIGX
  • GNFT
  • Stock Information
  • Founded
  • FIGX 2025
  • GNFT 1999
  • Country
  • FIGX United States
  • GNFT France
  • Employees
  • FIGX N/A
  • GNFT N/A
  • Industry
  • FIGX
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FIGX
  • GNFT Health Care
  • Exchange
  • FIGX Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • FIGX 193.9M
  • GNFT 216.7M
  • IPO Year
  • FIGX 2025
  • GNFT 2019
  • Fundamental
  • Price
  • FIGX $10.01
  • GNFT $4.19
  • Analyst Decision
  • FIGX
  • GNFT Strong Buy
  • Analyst Count
  • FIGX 0
  • GNFT 2
  • Target Price
  • FIGX N/A
  • GNFT $10.00
  • AVG Volume (30 Days)
  • FIGX 16.2K
  • GNFT 5.1K
  • Earning Date
  • FIGX 01-01-0001
  • GNFT 09-22-2025
  • Dividend Yield
  • FIGX N/A
  • GNFT N/A
  • EPS Growth
  • FIGX N/A
  • GNFT N/A
  • EPS
  • FIGX N/A
  • GNFT N/A
  • Revenue
  • FIGX N/A
  • GNFT $52,994,715.00
  • Revenue This Year
  • FIGX N/A
  • GNFT $3.14
  • Revenue Next Year
  • FIGX N/A
  • GNFT N/A
  • P/E Ratio
  • FIGX N/A
  • GNFT N/A
  • Revenue Growth
  • FIGX N/A
  • GNFT N/A
  • 52 Week Low
  • FIGX $9.95
  • GNFT $2.55
  • 52 Week High
  • FIGX $10.06
  • GNFT $6.03
  • Technical
  • Relative Strength Index (RSI)
  • FIGX N/A
  • GNFT 52.42
  • Support Level
  • FIGX N/A
  • GNFT $4.07
  • Resistance Level
  • FIGX N/A
  • GNFT $4.40
  • Average True Range (ATR)
  • FIGX 0.00
  • GNFT 0.15
  • MACD
  • FIGX 0.00
  • GNFT 0.01
  • Stochastic Oscillator
  • FIGX 0.00
  • GNFT 54.19

About FIGX FIGX Capital Acquisition Corp. Class A Ordinary Share

FIGX Capital Acquisition Corp is a blank check company.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: